![Matthew Korenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Korenberg
Directeur/Membre du Conseil chez
PFENEX INC.
Fortune : 448 294 $ au 31/07/2026
Profil
Matthew Edward Korenberg was the founder of Neurocircuit Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer & Director.
Current jobs include Director at Qualigen, Inc.; Director at The Pelican, Inc. since 2020; Director at Ligand UK Group Ltd. since 2018; Independent Director at Lifecore Biomedical, Inc. since 2024; and Chief Financial Officer, Secretary & Treasurer at Palvella Therapeutics, Inc. since 2024.
Former jobs include Director at Ligand UK Ltd.; Managing Director at Goldman Sachs & Co. LLC.
from 1999 to 2013; Independent Director at AIxCrypto Holdings, Inc. from 2020 to 2024; Director at Ligand UK Research Ltd.; and President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2022 to 2024.
Education includes undergraduate studies at the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 69 967 ( 0,19 % ) | 309 254 $ | 31/07/2026 | |
0,01 % | 12/06/2026 | 1 000 ( 0,01 % ) | 139 040 $ | 31/07/2026 |
Postes actifs de Matthew Korenberg
| Sociétés | Poste | Début |
|---|---|---|
| PFENEX INC. | Directeur/Membre du Conseil | 01/10/2020 |
| LIFECORE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 01/08/2024 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | 12/10/2018 |
Qualigen, Inc.
 Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Korenberg
| Sociétés | Poste | Fin |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | President | 31/10/2024 |
| AIXCRYPTO HOLDINGS, INC. | Directeur/Membre du Conseil | 03/10/2024 |
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | 19/03/2024 |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/08/2013 |
| VERNALIS | Directeur/Membre du Conseil | - |
Formation de Matthew Korenberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Qualigen, Inc.
Qualigen, Inc. Medical SpecialtiesHealth Technology Develops and manufactures automated blood testing systems | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Neurocircuit Therapeutics, Inc. | |
Qualigen Therapeutics, Inc.
 Qualigen Therapeutics, Inc. Packaged SoftwareTechnology Services Develops global ecosystem platform that integrates AI and blockchain systems to connect web apps | Technology Services |
